SpyGlass Pharma, Inc. Common Stock
$28.60
-$0.36 (-1.24%)
$27.13Day Range$29.41
Key Statistics
Market Cap
$956.61M
Shares Outstanding
33.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 6, 2026
Round Lot
100
Locale
US
Trading Data
Day Open
$29.21
Day High
$29.41
Day Low
$27.13
Volume
186.2K
VWAP
$28.56
Prev Close
$28.96
Transactions
--
Acc. Volume
--
About SpyGlass Pharma, Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384165 employees15326 ALTON PARKWAY, IRVINE, CA, 92618949-284-6904IPO Feb 6, 2026US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001778922
- Composite FIGI
- BBG01HDDMDS5
- Share Class FIGI
- BBG01HDDMDT4
- Ticker Root
- SGP
- SIC Code
- 3841
About SpyGlass Pharma, Inc. Common Stock (SGP) Stock
SpyGlass Pharma, Inc. Common Stock (SGP) closed the 2026-09-16 session at $28.60, down 1.24% versus the previous close (-0.36). The stock opened at $29.21 and traded between $27.13 and $29.41 during that session. Session trading volume was 186K shares. The volume-weighted average price (VWAP) is $28.56.
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
SpyGlass Pharma, Inc. Common Stock has a market capitalization of $956.6 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. SGP is listed on the XNAS exchange. The company employs approximately 65 people. SpyGlass Pharma, Inc. Common Stock is headquartered in IRVINE, CA. The recorded listing date is 2026-02-06.
On this page you can find market SGP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.